Jan Zítko

1.0k total citations
57 papers, 794 citations indexed

About

Jan Zítko is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Jan Zítko has authored 57 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Organic Chemistry, 28 papers in Molecular Biology and 12 papers in Computational Theory and Mathematics. Recurrent topics in Jan Zítko's work include Synthesis and biological activity (28 papers), Synthesis and Biological Evaluation (26 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (17 papers). Jan Zítko is often cited by papers focused on Synthesis and biological activity (28 papers), Synthesis and Biological Evaluation (26 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (17 papers). Jan Zítko collaborates with scholars based in Czechia, Slovakia and Belgium. Jan Zítko's co-authors include Martin Doležal, Jiřı́ Kuneš, Pavla Paterová, Ondřej Janďourek, Vladimı́r Kubı́ček, Stevan Armaković, Sanja J. Armaković, Christian Van Alsenoy, Klára Konečná and Y. Sheena Mary and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Jan Zítko

51 papers receiving 774 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Zítko Czechia 17 555 304 120 99 96 57 794
Sudershan K. Arora India 18 689 1.2× 206 0.7× 42 0.3× 76 0.8× 55 0.6× 28 1.1k
Marcelle de Lima Ferreira Brazil 12 673 1.2× 227 0.7× 32 0.3× 160 1.6× 67 0.7× 28 822
Seema Bag United States 16 343 0.6× 168 0.6× 41 0.3× 56 0.6× 116 1.2× 30 698
Adebayo A. Adeniyi South Africa 16 346 0.6× 237 0.8× 42 0.3× 51 0.5× 101 1.1× 67 720
Shwu‐Chen Tsay Taiwan 20 958 1.7× 317 1.0× 36 0.3× 159 1.6× 37 0.4× 79 1.4k
Alessandro K. Jordão Brazil 15 526 0.9× 188 0.6× 120 1.0× 48 0.5× 22 0.2× 23 832
Salah Belaıdı Algeria 20 647 1.2× 354 1.2× 61 0.5× 79 0.8× 620 6.5× 101 1.5k
Halina Niedbala Poland 10 524 0.9× 194 0.6× 31 0.3× 44 0.4× 34 0.4× 14 656
Yuan‐Qiang Hu China 14 864 1.6× 511 1.7× 29 0.2× 210 2.1× 66 0.7× 16 1.2k
Bahjat A. Saeed Iraq 16 458 0.8× 129 0.4× 202 1.7× 25 0.3× 54 0.6× 73 838

Countries citing papers authored by Jan Zítko

Since Specialization
Citations

This map shows the geographic impact of Jan Zítko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Zítko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Zítko more than expected).

Fields of papers citing papers by Jan Zítko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Zítko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Zítko. The network helps show where Jan Zítko may publish in the future.

Co-authorship network of co-authors of Jan Zítko

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Zítko. A scholar is included among the top collaborators of Jan Zítko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Zítko. Jan Zítko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pávek, Petr, et al.. (2025). The discovery of a new nonbile acid modulator of Takeda G protein‐coupled receptor 5: An integrated computational approach. Archiv der Pharmazie. 358(1). e2400423–e2400423. 1 indexed citations
2.
Janďourek, Ondřej, et al.. (2023). N -Pyrazinylhydroxybenzamides As Biologically Active Compounds: A Hit-Expansion Study and Antimicrobial Evaluation. Future Medicinal Chemistry. 15(19). 1791–1806.
3.
Janďourek, Ondřej, Klára Konečná, Pavla Paterová, et al.. (2023). Antimycobacterial pyridine carboxamides: From design to in vivo activity. European Journal of Medicinal Chemistry. 258. 115617–115617. 7 indexed citations
4.
Janďourek, Ondřej, et al.. (2022). Improving Antimicrobial Activity and Physico-Chemical Properties by Isosteric Replacement of 2-Aminothiazole with 2-Aminooxazole. Pharmaceuticals. 15(5). 580–580. 5 indexed citations
5.
Janďourek, Ondřej, Klára Konečná, Pavel Bárta, et al.. (2021). Design, synthesis and biological evaluation of substituted 3-amino-N-(thiazol-2-yl)pyrazine-2-carboxamides as inhibitors of mycobacterial methionine aminopeptidase 1. Bioorganic Chemistry. 118. 105489–105489. 8 indexed citations
6.
Zítko, Jan, et al.. (2021). Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: An up-to-date review. Bioorganic Chemistry. 110. 104806–104806. 30 indexed citations
7.
Janďourek, Ondřej, Klára Konečná, Pavla Paterová, et al.. (2017). 3-Substituted N-Benzylpyrazine-2-carboxamide Derivatives: Synthesis, Antimycobacterial and Antibacterial Evaluation. Molecules. 22(3). 495–495. 9 indexed citations
8.
Zítko, Jan & Martin Doležal. (2015). Indole-2-carboxamide derivatives: a patent evaluation of WO2015036412A1. Expert Opinion on Therapeutic Patents. 25(12). 1487–1494. 1 indexed citations
9.
Konečná, Klára, Pavla Paterová, Vladimı́r Kubı́ček, et al.. (2015). Synthesis and Biological Evaluation of N-Alkyl-3-(alkylamino)-pyrazine-2-carboxamides. Molecules. 20(5). 8687–8711. 14 indexed citations
10.
Zítko, Jan, Pavla Paterová, Jana Mandíková, et al.. (2014). Synthesis and antimycobacterial evaluation of 5-alkylamino-N-phenylpyrazine-2-carboxamides. Bioorganic & Medicinal Chemistry. 23(1). 174–183. 18 indexed citations
11.
Paterová, Pavla, Jana Mandíková, Vladimı́r Kubı́ček, et al.. (2013). Alkylamino derivatives of pyrazinamide: Synthesis and antimycobacterial evaluation. Bioorganic & Medicinal Chemistry Letters. 24(2). 450–453. 20 indexed citations
12.
Zítko, Jan, et al.. (2012). Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles. Bioorganic & Medicinal Chemistry Letters. 22(4). 1598–1601. 15 indexed citations
13.
Zítko, Jan, Martin Doležal, Marcela Vejsová, et al.. (2011). Synthesis and antimycobacterial properties of N-substituted 6-amino-5-cyanopyrazine-2-carboxamides. Bioorganic & Medicinal Chemistry. 19(4). 1471–1476. 31 indexed citations
14.
Doležal, Martin, et al.. (2011). Antimycobacterial Evaluation of Pyrazinoic Acid Reversible Derivatives. Current Pharmaceutical Design. 17(32). 3506–3514. 16 indexed citations
15.
Doležal, Martin, et al.. (2009). Substituted N-Phenylpyrazine-2-carboxamides: Synthesis and Antimycobacterial Evaluation. Molecules. 14(10). 4180–4189. 26 indexed citations
16.
Zítko, Jan. (2008). Some remarks on the restarted and augmented GMRES method.. 31. 221–227. 4 indexed citations
17.
Zítko, Jan. (1984). Convergence of extrapolation coefficients. Applications of Mathematics. 29(2). 114–133. 2 indexed citations
18.
Zítko, Jan. (1983). Improving the convergence of iterative methods. Applications of Mathematics. 28(3). 215–229. 4 indexed citations
19.
Zítko, Jan. (1974). Kellogg's iterations for general complex matrix. Applications of Mathematics. 19(5). 342–365. 1 indexed citations
20.
Zítko, Jan, et al.. (1967). Contribution to the successive overrelaxation method. Applications of Mathematics. 12(3). 161–170. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026